PEPG Insider Trading Activity and SEC Form 4 Filings
PEPG insider trading summary
Over the past 12 months, insiders at PepGen Inc. (PEPG) reported 7 sales worth $59K by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $59K.
Latest PEPG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 21, 2026 | Kasra Kasraian | Chief Technical Officer | Sell | $2K (1,233 @ $1.41) |
| Mar 4, 2026 | Noel Donnelly | Chief Financial Officer | Sell | $329 (52 @ $6.33) |
| Mar 4, 2026 | Paul Streck | EVP, Head of R&D | Sell | $11K (1,832 @ $6.23) |
| Mar 4, 2026 | Paul Streck | EVP, Head of R&D | Sell | $296 (47 @ $6.29) |
| Mar 4, 2026 | James G McArthur | President and CEO | Sell | $829 (131 @ $6.33) |
| Mar 4, 2026 | James G McArthur | President and CEO | Sell | $32K (5,144 @ $6.23) |
| Mar 4, 2026 | Noel Donnelly | Chief Financial Officer | Sell | $13K (2,032 @ $6.23) |
| Sep 30, 2025 | Oxford Science Enterprises plc | Insider | Buy | $640K (200,000 @ $3.20) |
| Sep 26, 2025 | Ra Capital Management, L.P. | Insider | Buy | $30.0M (9,375,000 @ $3.20) |
| Sep 26, 2025 | RA Capital Healthcare Fund LP | Director | Buy | $30.0M (9,375,000 @ $3.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.